Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Biocartis Idylla

Biocartis Idylla BRAF Mutation Test

Introducing Biocartis Idylla – BRAF molecular results in as little as 90 minutes.

About 50 percent of all melanomas harbor mutations in the BRAF oncogene. Idylla™ BRAF Mutation Test detects BRAF mutations directly from FFPE tissue sections in 90 minutes with less than 2 minutes hands-on time.

  • Detection of BRAF V600E, E2, D, K, R and M mutations

  • 90 minutes total turnaround time

  • Less than 2 minutes hands-on time

  • Directly from FFPE tissue sections

  • Highly sensitive & standardized

  • Contamination-controlled design

The Biocartis Idylla™ BRAF Mutation Test has demonstrated excellent analytical sensitivity. It can detect BRAF V600E, E2, D, K, R and M mutations at an analytical sensitivity of 1% of mutant in wild type background in FFPE samples.

Find out more about the Biocartis Idylla™ BRAF Mutation Test

View Brochure>

Discover Biocartis Idylla

View Brochure>

Request a demonstration

Contact us >

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.



Request a Quote

Request Quote

Recent Posts

Invivoscribe – LymphoTrack Flex

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.Identifying clonality and determining the frequency of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements…

Read full article

Invivoscribe – NPM1 MRD Assay now available globally

Invivoscribe’s NPM1 MRD Assay is an NGS-based, targeted, deep-sequencing assay that detects and monitors DNA sequences specific to identified mutations from the primary sample identified at diagnosis with an allelic sensitivity…

Read full article

ZytoVision – New ZytoLight Probes

NECTIN4  |  MALT1/IGH  |  TNFRSF14/1q25  |  PLAG1 (more…)

Read full article